XOMA Royalty Corporation (XOMA)Healthcare | Biotechnology | EmeryVille, United States | NasdaqGM
39.71 USD
+0.10
(0.252%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 39.71 Short-term: ★★★★☆ | Long-term: ★★★★★ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:21 a.m. EDT
XOMA presents a dichotomy: a statistically fractured short-term model implying flatness (-0.1% predicted move) versus an undeniable long-term strategic realignment driving exceptional fundamentals. The recent acquisitions (Generation Bio, Turnstone) have inflated revenue growth to 58%, yet the balance sheet remains thin on cash and heavy with debt. However, the 'Moderate Buy' consensus and the complete lack of speculative put positioning signal that smart capital views this restructuring as a high-conviction turnaround. The recent 12% drop likely created a dislocation that liquidity players are already filling, with the real story playing out in the multi-year recovery rather than weekly volatility. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.128572 |
| AutoARIMA | 0.130440 |
| MSTL | 0.130513 |
| AutoTheta | 0.194279 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 21.72 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.069 |
| Excess Kurtosis | -0.26 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2025-01-02 |
| Debt to Equity Ratio | 126.544 |
| Revenue per Share | 4.317 |
| Market Cap | 473,173,632 |
| Trailing P/E | 27.20 |
| Forward P/E | 18.56 |
| Beta | 0.68 |
| Profit Margins | 60.81% |
| Previous Name | XOMA Corporation |
| Website | https://www.xoma.com |
As of April 19, 2026, 12:21 a.m. EDT: Speculators exhibit a decisive bias toward calls over puts. May and June call activity shows significant Volume-Over-Information (Vol-OI) imbalance on strikes around the $30 strike, while recent 'New Flow' into $17.5 calls (though priced at OTM relative to current price, the data suggests flow dynamics) indicates buying. Put activity is negligible, with near-zero Volume and Open Interest across all expirations and strikes analyzed. The implied volatility is heavily skewed to calls, suggesting a one-way positive price expectation.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.79764605 |
| Address1 | 2,200 Powell Street |
| Address2 | Suite 310 |
| All Time High | 11,587.5 |
| All Time Low | 3.96 |
| Ask | 50.81 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 173,430 |
| Average Daily Volume3 Month | 241,848 |
| Average Volume | 241,848 |
| Average Volume10Days | 173,430 |
| Beta | 0.684 |
| Bid | 28.95 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 7.074 |
| City | EmeryVille |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 39.71 |
| Current Ratio | 3.368 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 40.74 |
| Day Low | 39.36 |
| Debt To Equity | 126.544 |
| Display Name | XOMA Royalty |
| Dividend Date | 1,476,748,800 |
| Earnings Call Timestamp End | 1,773,835,200 |
| Earnings Call Timestamp Start | 1,773,835,200 |
| Earnings Timestamp | 1,773,837,000 |
| Earnings Timestamp End | 1,778,675,400 |
| Earnings Timestamp Start | 1,778,675,400 |
| Ebitda | 14,356,000 |
| Ebitda Margins | 0.27528998 |
| Enterprise To Ebitda | 37.692 |
| Enterprise To Revenue | 10.376 |
| Enterprise Value | 541,106,432 |
| Eps Current Year | 2.14 |
| Eps Forward | 2.14 |
| Eps Trailing Twelve Months | 1.46 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,735,862,400 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 29.0602 |
| Fifty Day Average Change | 10.649799 |
| Fifty Day Average Change Percent | 0.3664737 |
| Fifty Two Week Change Percent | 79.7646 |
| Fifty Two Week High | 40.74 |
| Fifty Two Week High Change | -1.0300026 |
| Fifty Two Week High Change Percent | -0.02528234 |
| Fifty Two Week Low | 20.95 |
| Fifty Two Week Low Change | 18.759998 |
| Fifty Two Week Low Change Percent | 0.89546525 |
| Fifty Two Week Range | 20.95 - 40.74 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 518,448,600,000 |
| Float Shares | 9,019,960 |
| Forward Eps | 2.14 |
| Forward P E | 18.556074 |
| Free Cashflow | -14,235,375 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 14 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.96717 |
| Gross Profits | 50,437,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.040110003 |
| Held Percent Institutions | 0.73352 |
| Implied Shares Outstanding | 11,915,730 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ir Website | http://investors.xoma.com/ |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,476,748,800 |
| Last Split Factor | 1:20 |
| Long Business Summary | XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. |
| Long Name | XOMA Royalty Corporation |
| Market | us_market |
| Market Cap | 473,173,632 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_36769 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | 18,516,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 473,292,795 |
| Number Of Analyst Opinions | 4 |
| Open | 40.47 |
| Operating Cashflow | 2,871,000 |
| Operating Margins | 0.15861 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Phone | 510 204 7200 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 39.71 |
| Post Market Time | 1,776,456,605 |
| Prev Name | XOMA Corporation |
| Previous Close | 39.61 |
| Price Eps Current Year | 18.556074 |
| Price Hint | 2 |
| Price To Book | 5.6135144 |
| Price To Sales Trailing12 Months | 9.073494 |
| Profit Margins | 0.6081 |
| Quick Ratio | 3.187 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0999985 |
| Regular Market Change Percent | 0.252458 |
| Regular Market Day High | 40.74 |
| Regular Market Day Low | 39.36 |
| Regular Market Day Range | 39.36 - 40.74 |
| Regular Market Open | 40.47 |
| Regular Market Previous Close | 39.61 |
| Regular Market Price | 39.71 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 174,131 |
| Return On Assets | 0.02881 |
| Return On Equity | 0.34120998 |
| Revenue Growth | 0.579 |
| Revenue Per Share | 4.317 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 11,915,730 |
| Shares Percent Shares Out | 0.1173 |
| Shares Short | 1,397,743 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,378,226 |
| Short Name | XOMA Royalty Corporation |
| Short Percent Of Float | 0.22610001 |
| Short Ratio | 12.77 |
| Source Interval | 15 |
| State | CA |
| Symbol | XOMA |
| Target High Price | 97.0 |
| Target Low Price | 50.0 |
| Target Mean Price | 65.75 |
| Target Median Price | 58.0 |
| Total Cash | 83,290,000 |
| Total Cash Per Share | 6.996 |
| Total Debt | 131,555,000 |
| Total Revenue | 52,149,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.46 |
| Trailing P E | 27.19863 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 30.47365 |
| Two Hundred Day Average Change | 9.236349 |
| Two Hundred Day Average Change Percent | 0.30309296 |
| Type Disp | Equity |
| Volume | 174,131 |
| Website | https://www.xoma.com |
| Zip | 94,608 |